Today: 20 June 2026

Bank of America (BAC) Stock: What to Know Before the Market Opens on Dec. 22, 2025

Bank of America (BAC) Stock: What to Know Before the Market Opens on Dec. 22, 2025

Bank of America shares closed Friday at $55.27, up 1.86% on heavy volume ahead of the holiday week. Oppenheimer raised its price target to $63 from $55, maintaining an “outperform” rating. The next earnings report is set for Jan. 14, with analysts expecting Q4 EPS of about $0.96, up from $0.82 a year ago. CEO Brian Moynihan recently signaled potential high single-digit to 10% growth in trading revenue for Q4.
22 December 2025
·
Mastercard (MA) Stock: What to Know Before the Market Opens on December 22, 2025

Mastercard (MA) Stock: What to Know Before the Market Opens on December 22, 2025

Mastercard shares closed at $572.23 on Friday ahead of the U.S. market reopening Monday, with analysts maintaining a “Strong Buy” consensus and average price targets in the mid-$600s. The company faces ongoing litigation over a proposed $38 billion swipe-fee settlement, which major retailers have urged a judge to reject, citing insufficient relief.
22 December 2025
Goldman Sachs Stock (GS): What to Know Before the Market Opens on Dec. 22, 2025 — Latest News, Analyst Forecasts, and Key Catalysts

Goldman Sachs Stock (GS): What to Know Before the Market Opens on Dec. 22, 2025 — Latest News, Analyst Forecasts, and Key Catalysts

Goldman Sachs closed at $893.48 on Dec. 19, near its 52-week high of $919. Wall Street rates the stock “Hold” with a mean 1-year price target of $793. The firm’s Q4 2025 earnings are scheduled for Jan. 15, 2026. Goldman has reorganized its investment-banking teams around AI and digital infrastructure and agreed to acquire Innovator Capital Management.
22 December 2025
·
Citigroup (C) Stock: What to Know Before the Market Opens on Dec. 22, 2025

Citigroup (C) Stock: What to Know Before the Market Opens on Dec. 22, 2025

Citigroup shares closed at $114.86 on Friday, near 2025 highs, as investors weighed recent regulatory relief. The Federal Reserve ended three confidential supervisory actions tied to trading risk, and the OCC removed a 2024 amendment to Citi’s 2020 consent order. Citi’s Q4 earnings are set for Jan. 14, 2026. The underlying 2020 consent order remains in effect.
22 December 2025
·
AbbVie Stock (ABBV) Before the Market Opens on Dec. 22, 2025: Drug-Pricing Talks, Dividend Signals, and the Next Catalysts

AbbVie Stock (ABBV) Before the Market Opens on Dec. 22, 2025: Drug-Pricing Talks, Dividend Signals, and the Next Catalysts

AbbVie closed at $226.82 on Friday, Dec. 19, up 1.8%, with trading volume spiking to 18.6 million shares, well above average. The company remains in talks with the White House as U.S. drug pricing reforms accelerate, including “most-favored-nation” deals and new TrumpRx programs. AbbVie is expected to visit the White House after the holidays for further negotiations.
22 December 2025
···
Alnylam Pharmaceuticals (ALNY) Stock: Nasdaq-100 Entry, Amvuttra Momentum, Analyst Targets and Key Risks to Know Before the Dec. 22, 2025 Market Open

Alnylam Pharmaceuticals (ALNY) Stock: Nasdaq-100 Entry, Amvuttra Momentum, Analyst Targets and Key Risks to Know Before the Dec. 22, 2025 Market Open

Alnylam Pharmaceuticals joins the Nasdaq-100 before the U.S. market opens Dec. 22, prompting index-tracking funds to adjust positions. Shares last closed at $400.23. The company’s drug Amvuttra recently secured routine NHS use in England and Health Canada approval for ATTR cardiomyopathy. Alnylam also announced a $250 million manufacturing expansion and new FDA recognition for its technology platform.
22 December 2025
···
Johnson & Johnson Stock (JNJ) Before the Market Opens on December 22, 2025: FDA Catalysts, Talc Litigation Headlines, Analyst Targets, and What to Watch

Johnson & Johnson Stock (JNJ) Before the Market Opens on December 22, 2025: FDA Catalysts, Talc Litigation Headlines, Analyst Targets, and What to Watch

Johnson & Johnson shares closed at $206.37 on Friday, about 4% below their 52-week high. A Minnesota jury awarded $65.5 million in a talc cancer case against the company, which plans to appeal. The FDA granted a priority review voucher for J&J’s Tecvayli-Darzalex multiple myeloma regimen, speeding regulatory timelines. Trading may see sharper moves this week due to holiday liquidity.
22 December 2025
Exxon Mobil (XOM) Stock: Key News, Analyst Forecasts, and What to Watch Before the U.S. Market Opens on Dec. 22, 2025

Exxon Mobil (XOM) Stock: Key News, Analyst Forecasts, and What to Watch Before the U.S. Market Opens on Dec. 22, 2025

Exxon Mobil shares last traded at $116.69, down 1.02%, as crude prices hover near multi-year lows. Oil rebounded early Dec. 22 after the U.S. intercepted a Venezuelan tanker, but remains volatile. Exxon updated its 2030 plan, targeting $25 billion earnings growth and raising output goals. CFO Kathy Mikells will retire Feb. 1, 2026, with Neil Hansen set to succeed her.
22 December 2025
·
Salesforce Stock (NYSE: CRM): Key News, Analyst Forecasts, and What to Watch Before the U.S. Market Opens on Dec. 22, 2025

Salesforce Stock (NYSE: CRM): Key News, Analyst Forecasts, and What to Watch Before the U.S. Market Opens on Dec. 22, 2025

Salesforce shares closed at $259.91 on Dec. 19, down nearly 21% year-to-date but up 14.6% for the month. The company announced a deal to acquire Qualified, an AI marketing firm, on Dec. 17. In its latest earnings, Salesforce reported Q3 revenue of $10.3 billion, up 9% year-over-year, and highlighted Agentforce and Data 360 annualized revenue reaching $1.4 billion, up 114%.
22 December 2025
·
Microsoft AI CEO Mustafa Suleyman Draws Superintelligence Red Lines as Costs, Talent Wars and Power Bills Collide

Microsoft AI CEO Mustafa Suleyman Draws Superintelligence Red Lines as Costs, Talent Wars and Power Bills Collide

Microsoft AI CEO Mustafa Suleyman said on Dec. 21 the company will halt any AI system that risks escaping human control, calling “containment” and “alignment” non-negotiable before releasing superintelligent tools. On the same day, U.S. senators pressed Microsoft and other firms on whether AI data centers are raising household electricity bills as their power use climbs.
22 December 2025
··
Starbucks Names Former Amazon Grocery Tech Leader Anand Varadarajan as CTO in Brian Niccol’s Turnaround Push

Starbucks Names Former Amazon Grocery Tech Leader Anand Varadarajan as CTO in Brian Niccol’s Turnaround Push

Starbucks named Anand Varadarajan, a longtime Amazon executive, as its new Chief Technology Officer, effective January 19, 2026. Varadarajan will oversee technology upgrades aimed at improving store speed and labor efficiency, following the previous CTO’s departure in the fall. CEO Brian Niccol is pushing a tech overhaul to address operational challenges in U.S. stores.
22 December 2025
·
AppLovin (NASDAQ: APP) Stock Preview: Key News, Analyst Targets, Financial Outlook, and Risks to Watch Before the Market Opens on Dec. 22, 2025

AppLovin (NASDAQ: APP) Stock Preview: Key News, Analyst Targets, Financial Outlook, and Risks to Watch Before the Market Opens on Dec. 22, 2025

AppLovin closed Friday at $721.37, up nearly 4%, with after-hours trading near $725. The company’s market cap stands at about $243.8 billion. AppLovin now operates solely as an advertising/software platform after selling its Apps Business on June 30, 2025. The stock faces ongoing short-seller scrutiny and reported regulatory attention over data practices.
22 December 2025
·
Nike (NKE) Stock: What to Know Before the U.S. Market Opens on Dec. 22, 2025 — Earnings Fallout, China Risks, Tariffs, and Wall Street Forecasts

Nike (NKE) Stock: What to Know Before the U.S. Market Opens on Dec. 22, 2025 — Earnings Fallout, China Risks, Tariffs, and Wall Street Forecasts

Nike shares closed at $58.71 on Friday, down 11% after a post-earnings selloff and hitting a seven-month low. Net income and EPS fell 32% in fiscal Q2 2026 despite a revenue increase, with margins pressured by tariffs and ongoing weakness in China. Wholesale revenue rose, but direct-to-consumer sales dropped. Analysts trimmed price targets, citing tariff risks and China uncertainty.
22 December 2025
···
CoreWeave Stock (CRWV) Before the Market Opens Dec. 22, 2025: The DOE “Genesis Mission” Boost, Debt Questions, Guidance, and Analyst Targets

CoreWeave Stock (CRWV) Before the Market Opens Dec. 22, 2025: The DOE “Genesis Mission” Boost, Debt Questions, Guidance, and Analyst Targets

CoreWeave shares surged 22.6% Friday to close at $83.00 after a volatile week that saw lows near $64. The rebound followed weeks of selling tied to concerns over debt-fueled growth and data-center delays. The company recently joined the U.S. Department of Energy’s Genesis Mission. CoreWeave projects 2025 revenue of $5.05–$5.15 billion and capital spending of up to $14 billion.
22 December 2025
·
Costco Stock (COST) Before the Market Open on Dec. 22, 2025: Key News, Earnings Takeaways, Analyst Forecasts, and What to Watch

Costco Stock (COST) Before the Market Open on Dec. 22, 2025: Key News, Earnings Takeaways, Analyst Forecasts, and What to Watch

Costco reported Q1 fiscal 2026 net sales of $65.98 billion, up 8.2%, with net income at $2.001 billion and diluted EPS of $4.50. Shares traded near $855.62 after a year of underperformance, as investors questioned valuation despite steady growth. Membership fees rose to $1.329 billion, with total paid members at 81.4 million. Roth Capital issued a rare sell call, citing softer membership and rising competition.
22 December 2025
··
Eli Lilly (LLY) Stock: What to Know Before the U.S. Market Opens on Dec. 22, 2025

Eli Lilly (LLY) Stock: What to Know Before the U.S. Market Opens on Dec. 22, 2025

Eli Lilly shares closed at $1,071.44 on Dec. 19, near record highs, as new late-stage data for oral GLP-1 candidate orforglipron showed less weight regain versus placebo after switching from injectables. Retatrutide posted 28.7% average weight loss in a Phase 3 trial. Lilly cut Zepbound prices in the U.S. and Canada. Orforglipron could receive FDA approval as early as March 2026.
22 December 2025
··
1 … 1,262 1,263 1,264 1,265 1,266 … 2,088

Stock Market Today

  • TD Cowen Confirms Hold Rating on Banco Bradesco S.A. Despite Undervaluation
    June 20, 2026, 3:53 PM EDT. TD Cowen maintained a Hold rating on Banco Bradesco S.A. (NYSE:BBD) following its fiscal Q1 2026 earnings release. The Brazilian bank reported R$36.9 billion in revenue, below estimates, causing a 6.4% stock decline. However, its loan portfolio grew 8.4% year-over-year to R$1.09 trillion, driven by secured lending. Banco Bradesco trades at a forward price-to-earnings (P/E) ratio of 6.7, below the sector average of 11, suggesting undervaluation. Analysts forecast over 31% upside in the next 12 months. Management maintains its 2026 guidance with expected loan growth of 9.5% and risk-adjusted net interest income growth of 12.5%. Investors are advised to weigh this against higher-upside, lower-risk AI stock opportunities amid broader market trends.

Latest articles

Robinhood Gains for Week as Layoffs, Trading Volumes Boost Shares

Robinhood Gains for Week as Layoffs, Trading Volumes Boost Shares

20 June 2026
Robinhood soared 16% in a holiday-shortened week after announcing a 10% workforce cut and $28 million in restructuring charges, as investors viewed the move as cost control amid record June trading volumes; risks remain from competition and potential disruption, according to SEC filings and Reuters.
Go toTop